Concern for Employer, Insurance Discrimination for Alzheimer's Patients

Share this content:
Concern for Employer, Insurance Discrimination for Alzheimer's Patients
Concern for Employer, Insurance Discrimination for Alzheimer's Patients

TUESDAY, March 27, 2018 (HealthDay News) -- U.S. adults express concerns about discrimination by employers and insurance for patients with Alzheimer's disease dementia, according to a study published online March 27 in Alzheimer's & Dementia.

Shana D. Stites, Psy.D., from the University of Pennsylvania in Philadelphia, and colleagues examined the prevalence of beliefs, attitudes, and expectations about Alzheimer's disease dementia in a random sample of 317 adults from the U.S. public. Data were analyzed to understand reactions toward a man with mild-stage Alzheimer's disease dementia.

The researchers found that more than half of respondents expected that the person would be discriminated against by employers and would be excluded from medical decision-making (both 55.3 percent). Close to half of respondents expected that the man's health insurance would be limited based on data in the medical record, a brain imaging result, or genetic test result (46.6, 45.6, and 44.7 percent, respectively).

"Public education and policies are needed to address concerns about employment and insurance discrimination," the authors write. "Studies are needed to discover how advances in diagnosis and treatment may change Alzheimer's disease stigma."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »